B2M and central nervous system cancer: Results showed that the areas under the curves(AUCs) varied from 63.24% to 70.31% among the three databases, indicating that B2M possessed a moderate sensitivity and specificity for predicting the mesenchymal molecular subtype of gliomas (Figure 4B).